These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8499625)

  • 41. Increased macrophage colony-stimulating factor levels in immune thrombocytopenic purpura.
    Zeigler ZR; Rosenfeld CS; Nemunaitis JJ; Besa EC; Shadduck RK
    Blood; 1993 Mar; 81(5):1251-4. PubMed ID: 8443386
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transient elevation of platelet count in patients with chronic idiopathic thrombocytopenic purpura: association with infection.
    Matano S; Kyoda K; Yamazaki H; Sugimoto T
    Acta Haematol; 2003; 109(2):104-7. PubMed ID: 12624496
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vincristine for refractory autoimmune thrombocytopenic purpura in pregnancy. A case report.
    Gross Z; Rodriguez JJ; Stalnaker BL
    J Reprod Med; 1995 Oct; 40(10):739-42. PubMed ID: 8551481
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Outline of treatment--strategy of initial therapy].
    Ohtake H; Miyazaki K; Higashihara M
    Nihon Rinsho; 2003 Apr; 61(4):587-92. PubMed ID: 12718080
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Autoimmune thrombocytopenic purpura.
    Bussel JB
    Hematol Oncol Clin North Am; 1990 Feb; 4(1):179-91. PubMed ID: 1690204
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pathophysiology of platelet destruction in immune (idiopathic) thrombocytopenic purpura.
    McFarland J
    Blood Rev; 2002 Mar; 16(1):1-2. PubMed ID: 11913982
    [TBL] [Abstract][Full Text] [Related]  

  • 47. B-cell hyperfunction in children with immune thrombocytopenic purpura persists after splenectomy.
    Giordano P; Cascioli S; Lassandro G; Marcellini V; Cardinale F; Valente F; Locatelli F; Carsetti R
    Pediatr Res; 2016 Feb; 79(2):262-70. PubMed ID: 26492283
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Autoimmune thrombocytopenic purpura.
    Ikehara S; Mizutani H; Kurata Y
    Crit Rev Oncol Hematol; 1995 Apr; 19(1):33-45. PubMed ID: 7741979
    [No Abstract]   [Full Text] [Related]  

  • 49. Life-threatening hypercoagulable state following splenectomy in ITP: successful management with aggressive antithrombotic therapy and danazol.
    Tiede MP; Ahn ER; Jy W; Scagnelli T; Bidot CJ; Horstman LL; Jimenez JJ; Ahn YS
    Clin Appl Thromb Hemost; 2005 Jul; 11(3):347-52. PubMed ID: 16015423
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antiplatelet antibodies in chronic immune thrombocytopenia and their role in platelet destruction and defective platelet production.
    McMillan R
    Hematol Oncol Clin North Am; 2009 Dec; 23(6):1163-75. PubMed ID: 19932426
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recognizing and treating secondary immune thrombocytopenic purpura associated with lymphoproliferative disorders.
    Liebman HA
    Semin Hematol; 2009 Jan; 46(1 Suppl 2):S33-6. PubMed ID: 19245932
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Does the site of platelet sequestration predict the response to splenectomy in adult patients with immune thrombocytopenic purpura?
    Navez J; Hubert C; Gigot JF; Navez B; Lambert C; Jamar F; Danse E; Lannoy V; Jabbour N
    Platelets; 2015; 26(6):573-6. PubMed ID: 25275667
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combination chemotherapy in refractory immune thrombocytopenic purpura.
    Figueroa M; Gehlsen J; Hammond D; Ondreyco S; Piro L; Pomeroy T; Williams F; McMillan R
    N Engl J Med; 1993 Apr; 328(17):1226-9. PubMed ID: 8464433
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Autoantibody-mediated complement activation on platelets is a common finding in patients with immune thrombocytopenic purpura (ITP).
    Najaoui A; Bakchoul T; Stoy J; Bein G; Rummel MJ; Santoso S; Sachs UJ
    Eur J Haematol; 2012 Feb; 88(2):167-74. PubMed ID: 21985182
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Childhood idiopathic thrombocytopenic purpura. Aggressive management of life-threatening complications.
    Lightsey AL; McMillan R; Koenig HM
    JAMA; 1975 May; 232(7):734-6. PubMed ID: 1173173
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Canine idiopathic thrombocytopenic purpura.
    Lewis DC; Meyers KM
    J Vet Intern Med; 1996; 10(4):207-18. PubMed ID: 8819045
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Danazol in non-splenectomized patients with refractory idiopathic thrombocytopenic purpura.
    Edelmann DZ; Knobel B; Virag I; Meytes D
    Postgrad Med J; 1990 Oct; 66(780):827-30. PubMed ID: 2099421
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A more practical therapy for low platelets.
    Torres G
    GMHC Treat Issues; 1996 Jan; 10(1):9-10. PubMed ID: 11363379
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Danazol therapy in refractory chronic immune thrombocytopenic purpura.
    Mazzucconi MG; Francesconi M; Falcione E; Ferrari A; Gandolfo GM; Ghirardini A; Tirindelli MC
    Acta Haematol; 1987; 77(1):45-7. PubMed ID: 3107321
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pilot study of ascorbic acid for the treatment of refractory immune thrombocytopenic purpura.
    Jubelirer SJ
    Am J Hematol; 1993 May; 43(1):44-6. PubMed ID: 8317460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.